We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Search Results

Showing 1-20 of 10,000 results
  1. Prognostic value of the liver fibrosis marker fibrosis-5 index in patients with severe isolated tricuspid regurgitation: comparison with fibrosis-4 index

    The fibrosis-4 index (FIB4), a liver fibrosis maker, has been shown to be associated with the prognosis in patients with severe isolated tricuspid...

    Mitsutaka Nakashima, Toru Miyoshi, ... Hiroshi Ito in Heart and Vessels
    Article Open access 23 April 2023
  2. Ovarian fibrosis: molecular mechanisms and potential therapeutic targets

    Ovarian fibrosis, characterized by the excessive proliferation of ovarian fibroblasts and the accumulation of extracellular matrix (ECM), serves as...

    Mengqing Gu, Yibo Wang, Yang Yu in Journal of Ovarian Research
    Article Open access 05 July 2024
  3. Interstitial Lung Abnormalities (ILA) and Pulmonary Fibrosis

    Purpose of Review

    This review identifies the similarities and differences between interstitial lung abnormalities (ILA) and pulmonary fibrosis in...

    Noriaki Wada, Kyung Soo Lee, Hiroto Hatabu in Current Pulmonology Reports
    Article 02 April 2024
  4. Inflammation accelerating intestinal fibrosis: from mechanism to clinic

    Intestinal fibrosis is a prevalent complication of IBD that that can frequently be triggered by prolonged inflammation. Fibrosis in the gut can cause...

    Shuzi Xin, Xiaohui Liu, ... Jingdong Xu in European Journal of Medical Research
    Article Open access 18 June 2024
  5. Liver fibrosis analysis using digital pathology

    Digital pathology has enabled the noninvasive quantification of pathological parameters. In addition, the combination of digital pathology and...

    Hisamitsu Miyaaki, Satoshi Miuma, ... Kazuhiko Nakao in Medical Molecular Morphology
    Article 09 July 2024
  6. Regulation of myofibroblast dedifferentiation in pulmonary fibrosis

    Idiopathic pulmonary fibrosis is a lethal, progressive, and irreversible condition that has become a significant focus of medical research due to its...

    Xuetao Ju, Kai Wang, ... Jun Yu in Respiratory Research
    Article Open access 18 July 2024
  7. Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis.

    Background

    Bronchiectasis is a condition characterized by abnormal and irreversible bronchial dilation resulting from lung tissue damage and can be...

    Heryk Motta, Júlia Catarina Vieira Reuwsaat, ... Lívia Kmetzsch in Respiratory Research
    Article Open access 18 May 2024
  8. Mitophagy in renal interstitial fibrosis

    As a high energy consumption organ, kidney relies on a large number of mitochondria to ensure normal physiological activities. Under specific...

    Jun Sun, Chong Liu, ... Zhao-An Guo in International Urology and Nephrology
    Article 14 July 2023
  9. Metabolomic insights into pulmonary fibrosis: a mendelian randomization study

    Background

    This study leverages a two-sample Mendelian Randomization (MR) approach to explore the causal relationships between 1,400 metabolites and...

    Wuyinuo Tang, Huanyu Jiang, ... Lvyuan He in BMC Pulmonary Medicine
    Article Open access 06 June 2024
  10. Intravoxel incoherent motion assessment of liver fibrosis staging in MASLD

    Purpose

    Partial correlation analysis was performed to account for the interference of steatosis changes and inflammatory factors, to determine the...

    Hao Ren, Hui Xu, ... Zhenghan Yang in Abdominal Radiology
    Article 10 March 2024
  11. TRPC6 Knockout Alleviates Renal Fibrosis through PI3K/AKT/GSK3B Pathway

    Objective

    Renal fibrosis is the ultimate pathway of various forms of acute and chronic kidney damage. Notably, the knockout of transient receptor...

    An-bang Sun, Fang-hua Li, ... Yan-hong Liao in Current Medical Science
    Article 15 May 2024
  12. Hepatic inflammatory responses in liver fibrosis

    Chronic liver diseases such as nonalcoholic fatty liver disease (NAFLD) or viral hepatitis are characterized by persistent inflammation and...

    Linda Hammerich, Frank Tacke in Nature Reviews Gastroenterology & Hepatology
    Article 03 July 2023
  13. Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation

    Background

    The relationship between liver fibrosis and inflammation and Mac-2-binding protein glycosylation isomer (M2BPGi) in patients with chronic...

    Haruki Uojima, Kazumi Yamasaki, ... Masashi Mizokami in Journal of Gastroenterology
    Article 16 April 2024
  14. Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan® to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

    Background

    Non-invasive tests are widely used to diagnose fibrosis in patients with non-alcoholic fatty liver disease (NAFLD), however, the optimal...

    Luis C. Bertot, Gary P. Jeffrey, ... Leon A. Adams in Digestive Diseases and Sciences
    Article Open access 22 March 2023
  15. Kidney fibrosis: from mechanisms to therapeutic medicines

    Chronic kidney disease (CKD) is estimated to affect 10–14% of global population. Kidney fibrosis, characterized by excessive extracellular matrix...

    Rongshuang Huang, Ping Fu, Liang Ma in Signal Transduction and Targeted Therapy
    Article Open access 17 March 2023
  16. Pathophysiology of Radiation Fibrosis Syndrome

    Purpose of Review

    The goal of this article is to provide an overview of radiation therapy followed by a description of the pathophysiology underlying...

    Cristina Kline-Quiroz, Hayden Byrd, ... Natalie Lockney in Current Physical Medicine and Rehabilitation Reports
    Article 16 May 2023
  17. Single-cell sequencing analysis fibrosis provides insights into the pathobiological cell types and cytokines of radiation-induced pulmonary fibrosis

    Background

    Radiotherapy is an essential treatment for chest cancer. Radiation-induced pulmonary fibrosis (RIPF) is an almost irreversible interstitial...

    Zhiyong Sun, Yutao Lou, ... Ping Huang in BMC Pulmonary Medicine
    Article Open access 28 April 2023
  18. Genetic-driven biomarkers for liver fibrosis through bioinformatic approach

    Background

    Liver fibrosis is a widespread chronic liver ailment linked to substantial mortality and limited therapeutic options. An in-depth...

    Ariza Julia Paulina, Y. Vitriyanna Mutiara, ... Wirawan Adikusuma in Egyptian Journal of Medical Human Genetics
    Article Open access 10 May 2024
  19. High Hydrostatic Pressure Exacerbates Bladder Fibrosis through Activating Piezo1

    Objective

    Bladder outlet obstruction (BOO) results in significant fibrosis in the chronic stage and elevated bladder pressure. Piezo1 is a type of...

    Bo-lang Deng, Dong-xu Lin, ... Zhong Chen in Current Medical Science
    Article 27 June 2024
  20. MAFLD identifies patients with significant hepatic fibrosis better than MASLD

    Background and aims

    Diagnostic criteria for metabolic dysfunction-associated steatotic liver disease (MASLD) have been proposed but not yet validated....

    Ziyan Pan, Said A. Al-Busafi, ... Mohammed Eslam in Hepatology International
    Article 08 May 2024
Did you find what you were looking for? Share feedback.